N-(1)-METHYL-N-(2)-(P-ANISYLDIPHENYLMETHYL)-9-[[1-(P-ANISYLDIPHENYLMETHYL)-3-FLUORO-2-PROPOXY]-METHYL]-GUANINE
Compound with spectra: 1 NMR
![N-(1)-METHYL-N-(2)-(P-ANISYLDIPHENYLMETHYL)-9-[[1-(P-ANISYLDIPHENYLMETHYL)-3-FLUORO-2-PROPOXY]-METHYL]-GUANINE](/api/compound/AKr3eg49cTO.png?ph=true&h=300&w=458 "N-(1)-METHYL-N-(2)-(P-ANISYLDIPHENYLMETHYL)-9-[[1-(P-ANISYLDIPHENYLMETHYL)-3-FLUORO-2-PROPOXY]-METHYL]-GUANINE")
| SpectraBase Compound ID | AKr3eg49cTO |
|---|---|
| InChI | InChI=1S/C50H46FN5O5/c1-55-47(57)45-46(53-48(55)54-49(36-16-8-4-9-17-36,37-18-10-5-11-19-37)38-24-28-42(58-2)29-25-38)56(34-52-45)35-60-44(32-51)33-61-50(39-20-12-6-13-21-39,40-22-14-7-15-23-40)41-26-30-43(59-3)31-27-41/h4-31,34,44H,32-33,35H2,1-3H3,(H,53,54) |
| InChIKey | FDZBXMWPPHJGJT-UHFFFAOYSA-N |
| Mol Weight | 815.9 g/mol |
| Molecular Formula | C50H46FN5O5 |
| Exact Mass | 815.348298 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
N-(1)-METHYL-N-(2)-(P-ANISYLDIPHENYLMETHYL)-9-[(4-FLUORO)-3-P-ANISYLDIPHENYLMETHOXY-METHYLBUTYL]-GUANINE
3,9-DIHYDRO-3-[(2-HYDROXYETHOXY)-METHYL]-6-[4-(ISOBUTYRYLAMINO)-PHENYL]-9-OXO-5H-IMIDAZO-[1,2-A]-PURINE
1-(1-BENZOYLETHYL)-9-[(1,3-DIHYDROXY-2-PROPOXY)-METHYL]-GUANINE
5'-O-(4,4'-DIMETHOXYTRITYL)-2'-DEOXYGUANOSINE
3'-O-ACETYL-5'-O-DIMETHOXYTRITYL-2'-DEOXYINOSINE
Valganciclovir 4TMS
5'-O-(4,4'-DIMETHOXYTRITYL)-N4-BENZOYL-2'-O-ETHYLCYTIDINE-TERT.-BUTYL-DISULFIDE
deoxy-N-acetyl-2-amino-9.beta.- D-(diacetyl)ribofuranosyl)-9H-purine-6(1H)-one
5'-O-(P,P'-DIMETHOXYTRITYL)-2'-DEOXYADENOSINE-3'-METHYL-H-PHOSPHONATE
6-(4-Chlorophenyl)-5-(diethylamino)-3-phenyl-7-triazolo[4,5-d]pyrimidinone
| Title | Journal or Book | Year |
|---|---|---|
| Syntheses of novel modified acyclic purine and pyrimidine nucleosides as potential substrates of herpes simplex virus type-1 thymidine kinase for monitoring gene expression | Canadian Journal of Chemistry | 2004 |